share_log

Truist Securities Maintains Hold on Fresenius Medical Care, Lowers Price Target to $24

Benzinga ·  Oct 11, 2023 15:55

Truist Securities analyst David Macdonald maintains Fresenius Medical Care (NYSE:FMS) with a Hold and lowers the price target from $28 to $24.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment